Biosimilar Manufacturing solution center
-
How To Successfully Isolate Your T Cells
10/7/2024
Explore the results of a study focusing on the early stages of the CAR T cell workflow, specifically the initial washing of leukapheresis followed by the isolation of T cells.
-
Production Of A Highly Concentrated Monoclonal Antibody
10/4/2024
Discover how you can achieve a final mAb concentration above 200 g/L while maintaining critical quality attributes.
-
Expert Voices: Why Aren't QC Labs Fully Automated Yet?
10/4/2024
Leading automation experts chime in on why QC labs, otherwise ideal for robotics, have been slow to adopt and standardize the technology.
-
Assessing A Targeted Molecular Method Against Traditional In Vitro Testing For Adventitious Virus Detection
10/3/2024
Discover a CHO AOF panel that provides rapid detection of relevant adventitious viral contaminants in bulk harvest material, and explore data showing equivalent sensitivity to the in vitro assay.
-
The Benefits Of Partnering With A CDMO Dedicated To Transparency And Robust Analytics
9/23/2024
Poland’s biomanufacturing scene presents an array of benefits to drug sponsors looking to partner globally, including cost-effectiveness, economic stability, and a culture that emphasizes a strong work ethic.
-
Extractables In Single-Use Systems Used In ADC Manufacturing
9/23/2024
To address concerns about using organic solvents in the ADC process, extractables studies were conducted on a disposable chromatography column housing and two different disposable flow paths.
-
5 Strategic Advantages Of Manufacturing ADCs In-house
9/20/2024
Outsourcing antibody-drug conjugate manufacturing is the status quo. This executive explains why her company chooses to do it themselves for reasons including quality control and cost management.
-
Outsourced Complex Protein Development Demands Special Considerations
9/20/2024
Complex protein therapeutic innovators are often orchestrating the work of three, four, or more outsourced manufacturing partners at once. What goes into their selection criteria? Experts from ADC and fusion protein sponsors weigh in, with bonus commentary from a CDMO process development specialist.
-
Accelerate CMC Development With Team Topologies
9/20/2024
A method of defining role boundaries for knowledge workers in the IT industry maps nicely to CMC process development for biologics and pharmaceutical manufacturing.
-
Upping Flow Of Advanced Technologies Into Commercial Biomanufacturing
9/12/2024
A set of tools NASA developed assessing new, rapidly developed and deployed technology could help biopharmas adopt advanced tech post-commercialization.